
    
      The trial was terminated prematurely on 28 March 2013, due to the inability to recruit the
      planned number of subjects. The decision to terminate the trial was not based on any safety
      or efficacy concerns and agreement to close the study in March 2013 was agreed with EMA prior
      to closure activity.
    
  